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Inducible nitric oxide synthase (iNOS) functions as a homodimer. In cell 
extracts, iNOS molecules partition both in cytosolic and particulate frac­
tions, indicating that iNOS exists as soluble and membrane associated 
forms. In this study, iNOS features were investigated in human intestinal 
epithelial cells stimulated with cytokines and in duodenum from mice 
exposed to flagellin. Our experiments indicate that iNOS is mainly associ­
ated with the particulate fraction of cell extracts. Confocal microscopy 
showed a preferential localization of iNOS at the apical pole of intestinal 
epithelial cells. In particulate fractions, iNOS dimers were more abundant 
than in the cytosolic fraction. Similar observations were seen in mouse 
duodenum samples. These results suggest that, in epithelial cells, iNOS 
activity is regulated by localization-dependent processes.
Keywords
dimerization; inducible nitric oxide synthase; 
intestinal epithelial cells; specific activity; 
subcellular distribution
Correspondence
E. Felley-Bosco, Institute of Pharmacology 
and Toxicology, Rue du Bugnon T1, 1005 
Lausanne, Switzerland 
Fax: +41 21 6925355 
Tel: +41 21 6925370 
E-mail: emanuela.felley-bosco@unil.ch
*These authors contributed equally to the 
work described.
Present addresses
tDepartamento de Ciencias Biológicas, 
Facultad de Ciencias Exactas, Universidad 
Nacional de La Plata, Argentina 
tThe Garvan Institute of Medical Research, 
Darlinghurst, Australia 
§lnstitut de Biologie de Lille, Groupe 
AVENIR, Equipe Mixte INSERM, Université 
E0364, Lille, France
(Received 16 September 2004, revised 15 
November 2004, accepted 16 November 2004)
doi: 10.1111/j.1742-4658.2004.04484.X
The inducible nitric oxide synthase (iNOS) protein is 
responsible for sustained release of nitric oxide (NO) 
and is typically synthesized in response to proinflam- 
matory stimuli [1]. iNOS protein is induced in a large 
variety of human diseases, including intestinal disorders 
such as chronic inflammatory bowel diseases and colon 
adenocarcinoma [2-4]. The pathobiological function of 
NO still remains largely uncertain in view of the
multiple and even opposite effects of NO. In fact, 
besides the amount of NO produced, it has been 
recently suggested that the NO-mediated actions 
depend on many other factors such as the nature of 
iNOS induction signal, the cellular and subcellular site 
of production, subsequent interactions with other cell 
components and the redox environment [5-7]. 
Although iNOS was originally described as a cytosolic
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protein [8], it is distributed between the cytosol and 
particulate fraction in activated macrophages [9-11]. It 
is also present in the particulate but not the cytosolic 
fraction from guinea pig skeletal muscle [12] and it 
localizes in vivo to the apical domain of human bron­
chial and kidney epithelial cells [13], iNOS protein is 
active in a dimeric form [14] but both dimers and mo­
nomers can be found in the cytoplasm. About 60% of 
cytosolic iNOS are dimeric in activated murine macro­
phages [15] and 70% in activated rat hepatocytes [16]. 
However, nothing is known about the dimer/monomer 
ratio of particulate iNOS. This may be relevant for 
understanding the control of iNOS and defining target­
ing strategies for iNOS inhibition. The aim of this 
study was therefore to characterize iNOS activity both 
in vitro, using cytosolic and particulate fraction of acti­
vated human intestinal epithelial cells [17], and in vivo, 
using duodenum samples from mice exposed to bacter­
ial flagellin, which is known to up-regulate iNOS 
expression in intestinal epithelial cells [18].
Results
Subcellular distribution of iNOS protein and 
activity in vitro
The distribution of iNOS protein in the cytosol and 
particulate fraction was examined in DLD-1 cells 
exposed to cytokines. To determine the partitioning of 
iNOS into soluble cytosolic and insoluble membrane- 
associated forms, cell fractionation was performed. As 
expected, lactate dehydrogenase activity was recovered 
at 98 ± 4% (n = 4) in the cytosolic fraction, while 
membrane protein Na+/K + -ATPase was detected only 
in the particulate fraction (Fig. 1A), indicating that the 
fractionation procedure is effective. iNOS protein was 
distributed at 66 ± 2% and 34 ± 2% in the particu­
late fraction and cytosol, respectively (Fig. 1B,C), lead­
ing to a particulate to cytosol ratio of 2.0 ± 0.1. To 
investigate whether iNOS was delivered as an active 
enzyme, citrulline production was also determined. 
Interestingly, compared to the iNOS protein ratio, 
iNOS activity partitioned in higher proportion in par­
ticulate vs. cytosolic fraction (66 ± 2% vs. 19 ± 1%, 
respectively) (Fig. ID). In conclusion, iNOS specific 
activity was 1.8 ± 0.1-fold higher for particulate­
bound iNOS than for the cytosolic one (P < 0.001).
Subcellular distribution of iNOS dimers 
and monomers
To further characterize iNOS activity, various solubili­
zation protocols as described below were applied to
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Fig. 1. Subcellular distribution of iNOS in human cultured intestinal 
cells. DLD-1 cells were incubated with cytokines for 14 h before 
cell fractionation. (A) Distribution of Na+/K+-ATPase or LDH in cyto­
sol (C) and particulate (P) fractions. (B) Subcellular distribution of 
iNOS protein. Equal volumes of the cytosolic and particulate were 
analyzed. (C) Densitometric analysis of iNOS protein distribution. 
The protein amount in each fraction was expressed relative to the 
iNOS amount found in homogenate and values are the means ± 
SEM from seven independent experiments. (D) Subcellular distribu­
tion of iNOS activity. The enzyme activity was determined by the 
amount of citrulline produced in cytosol vs. resuspended particulate 
fraction and was expressed as percentage of the production meas­
ured in the whole cell homogenate (64.3 ± 6.3 pmol-min 1-mg 
protein1 n = 7). Values are the means ± SEM from seven 
independent experiments.
particulate fractions. As shown in Fig. 2A, complete 
iNOS protein solubilization was achieved by Triton 
X-100 (TX-100)/NaCl or Lubrol/sodium deoxycholate
B
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Fig. 2. Effect of salts and detergents on iNOS association with 
membranes in cultured cells. (A) Particulate fractions prepared from 
cytokine-treated cells were extracted with 1 m KCI or incubated for 
1 h with one of the following components prepared in lysis buffer: 
0.1m Na2CO3 pH 11; 125 mM NaCI; 1% TX-100; 1% TX-100 
together with 125 mM NaCI; or sonicated after addition of 
Lubrol/DOC. Soluble (S) and insoluble (I) material were separated 
by centrifugation at 100 000 g. The insoluble pellet was resuspend­
ed by sonication in the same volume as supernatant and equal vol­
umes of the two fractions were loaded. (B) Particulate fractions 
prepared from DLD-1 cells transfected with iNOS were incubated 
for 1 h with one of the following components prepared in lysis buf­
fer: 1% TX-100; 1% TX-100 together with 125 mM NaCI; or soni­
cated after addition of Lubrol/DOC. Soluble (S) and insoluble 
material (I) were separated by centrifugation at 100 000 g. The 
insoluble pellet was resuspended by sonication in the same volume 
as supernatant and equal volumes of the two fractions were loa­
ded. Blots shown are representative of three independent experi­
ments.
(DOC). However, TX-100/NaCl reduced iNOS activity 
by 51 ± 2% (n — 3). Solubilization with Lubrol/DOC 
was highly effective compared to other methods and 
resulted in recovery of most iNOS activity (91 ± 6%) 
indicating that this method is more appropriate to sol­
ubilize functional iNOS.
In order to determine the influence of cytokine sign­
aling on biochemical properties of iNOS, DLD-1 cells 
transfected with iNOS were investigated. As in cyto­
kine-stimulated cells, complete iNOS solubilization 
from the particulate fraction was obtained with 
TX-100/NaCl or Lubrol/DOC (Fig. 2B). In transfected 
cells it was also possible to verify that the same activ­
ity was recovered when cells were harvested either in 
lysis buffer or in Lubrol/DOC (data not shown), indi­
cating that treatment with these detergents does not 
result in artificial increase of iNOS activity.
Dimer Monomer
Fig. 3. Distribution of iNOS monomers and dimers in solubilized 
particulate fraction (P) and cytosol (C) of DLD-1 cells stimulated for 
14 h with cytokines. Lubrol/DOC extracts of particulate fraction 
and cytosols were fractionated by gel filtration chromatography and 
column fractions were analyzed by SDS/PAGE and Western blot. 
Fractions were designated to contain iNOS dimers or monomers 
based on the estimated molecular mass of the gel filtration fraction. 
Blot shown is representative of three independent experiments.
Taken together these data indicate that in epithelial 
intestinal cells iNOS intrinsically associates with 
particulate matter and intact activity can be extracted 
with Lubrol/DOC.
Because iNOS activity requires dimerization [14], we 
investigated iNOS oligomerization in cell fractions using 
gel filtration chromatography, which allows definition 
of the amount of monomers and dimers. Western blot 
analysis of chromatography fractions showed that only 
dimers were present in the particulate compartment 
(Fig. 3). In contrast, some cytosolic iNOS is in mono­
meric form (monomers/dimers estimated to 0.33 ± 
0.06, w = 3). Using this information it is possible to cal­
culate how much of the protein present in the cytosol 
(34% of total iNOS, Fig. 1C) is in the dimeric form. 
Indeed total protein in this compartment is represented 
by the sum of monomer plus dimer. Knowing that 
monomer = 0.33 x dimer, total iNOS protein is equival­
ent to 1.33 x dimer. Therefore, the amount of total cel­
lular dimer that is cytosolic dimer was estimated to 26% 
(34%/1.33). Thus, iNOS specific activity standardized 
to iNOS dimer levels was not significantly different in 
particulate-associated and cytosolic iNOS. In conclu­
sion, these results suggest that the prevalence of iNOS 
dimers is essential for enrichment in iNOS activity 
within the particulate fraction of epithelial cells.
Apical distribution of iNOS in intestinal epithelial 
cells
To get more insight into the localization of iNOS in 
intestinal cells, Caco-2 cells were investigated. Caco-2 
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cells spontaneously differentiate to enterocyte-like cells 
when they are cultured for 20 days after confluence 
onto plastic or for 10 days on filters. At this stage they 
form polarized monolayers sealed by tight junctions, 
and display a well-developed apical brush border mem­
brane expressing specific enterocyte hydrolases [19]. 
As described previously [20], iNOS protein decreased 
upon differentiation in Caco-2 cells (Fig. 4A, left). 
After cytokine addition, iNOS expression was dramat­
ically increased in Caco-2 cells in both proliferating 
and differentiated cells (Fig. 4A, left). iNOS was also 
expressed after Caco-2 transfection with human iNOS 
cDNA (Fig. 4A, right). As in DLD-1 cells, iNOS was 
mainly associated to particulate matter in cytokine- 
activated or iNOS-transfected cells (data not shown). 
To correlate the iNOS partitioning in the particulate 
fraction to a specific subcellular distribution, immuno­
staining was performed on differentiated enterocytes
A Proliferative Differentiated
Cytokine - ♦ ♦ 
mock iNOS
iNOS
, actin
6h cytokines Control■
Fig. 4. iNOS localizes to the apical domain of polarized intestinal 
epithelial cells. (A) Western blot analysis of iNOS expression 15 h 
after cytokine stimulation of proliferative vs. differentiated cells 
(left) or in Caco-2 cells transfected with iNOS (right). Actin was 
used as control for protein loading. (B) XZ confocal sections of cyto­
kine treated Caco-2 cells (left) or iNOS transfected Caco-2 cells 
(bottom right, not all transfected cells expressed iNOS). Cells were 
immunostained using anti-iNOS and phalloidine (F-actin detection). 
Only F-actin staining was observed when sections from cells 
exposed to cytokine for 15 h were stained without the iNOS pri­
mary antibody (control: upper right). The arrows indicate the posi­
tion of the filter (basolateral side of cells). Scale bar = 6 pm.
iNOS transfected -4
B
(Fig. 4B). Confocal microscopy showed that iNOS 
localized to the apical domain of enterocytes and 
colocalized with filamentous actin (Fig. 4B, left). The 
apical distribution was independent of cytokine stimu­
lation as assessed with Caco-2 cells transfected with 
human iNOS cDNA (Fig. 4B, bottom right).
Taken together, these data suggest a specific local­
ization of iNOS to apical domains of intestinal epithe­
lial cells.
Particulate fraction association of iNOS in vivo
In order to determine the distribution of iNOS in 
intestinal epithelial cells in vivo, experiments were con­
ducted in mice injected with bacterial flagellin. Flagel- 
lin activates Toll-like receptor 5, which induces iNOS 
expression in intestinal epithelial cells in vivo [18]. 
Quantitative RT-PCR showed five-fold induction of 
iNOS mRNA levels in the duodenum of flagellin-trea- 
ted compared to untreated animals (Fig. 5A). We also 
found a 50-fold induction of iNOS mRNA levels in 
microdissected epithelium from villi (Fig. 5A), which 
indicates that epithelial cells were the main source of 
iNOS. In addition, production of iNOS protein was 
significantly up-regulated in mice exposed to flagellin 
(Fig. 5B). Immunostaining of duodenum sections 
revealed that iNOS was distributed apically in
Bduodenum
I Microdissected 
epithelium
E 
w
Fig. 5. Expression of iNOS in duodenum tissue of mice. (A) Quanti­
fication of iNOS mRNA induction by flagellin in whole tissue and 
microdissected epithelium from villi assessed by real-time PCR. (B) 
Western blot analysis of iNOS protein expression in control or flag- 
ellin-exposed mice. Actin was used as control for protein loading.
£20
B)10
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Fig. 6. Subcellular distribution of iNOS in murine duodenum tissue. 
(A) Duodenum sections of flagellin-exposed or control mice were 
immunostained using anti-iNOS IgG. Each condition is representa­
tive of three mice. Scale bar = 40 pm. (B) Homogenate (H), cytoso­
lic (C), Lubrol/DOC-extracted particulate fractions (S) and insoluble 
pellet (I) were analyzed by Western blot (left). Densitometric ana­
lysis of ¡NOS protein and distribution of iNOS activity in cytosol vs. 
Lubrol/DOC extracts (right). Whole duodenum homogenate activity 
amounted to 32 ± 14 pmol citrulline-min~1-mg protein-1 (n = 4). 
Values are the means ± SEM from four independent experiments.
intestinal crypts (Fig. 6A) corroborating the observa­
tion in cultured polarized cells. Soluble and particulate 
fractions were extracted from intestinal homogenate 
from flagellin exposed mice and analyzed by Western 
blot (Fig. 6B, left). We found that iNOS protein was 
4.6-fold more abundant in the particulate fraction than 
in the cytosol (82 ± 10% vs. 18 ± 10%, respectively). 
iNOS activity was distributed 87 ± 12% in the partic­
ulate fraction and 13 ± 12% in the cytosolic fraction 
(Fig. 6B, right). Thus, iNOS activity normalized by 
total iNOS protein was 1.5-fold higher for particulate­
bound iNOS than for the cytosolic (P < 0.05).
The iNOS monomer/dimer ratio was 0.60 ± 0.08 
(n = 3) for the cytosolic fraction and 0.20 ± 0.04 
(n = 3) for the particulate fraction. Using the same 
calculation as for cultured cells, the amount of total 
dimer that is cytosolic or particulate dimer was estima­
ted to 11% (18%/1.6) and 69% (82%/1.2), respect­
ively. Therefore, the preferential partitioning of iNOS 
activity into the particulate fraction probably results 
from the enrichment in iNOS dimers.
Discussion
While the occurrence of iNOS in the particulate cellu­
lar fraction has been known for several years [9- 
11,13], the biological significance of this association is 
not clear at the moment. Our results showed that both 
in vitro and in vivo, most iNOS protein or activity is 
associated with the particulate fraction in intestinal 
epithelial cells. These results are consistent with iNOS 
features in neutrophils from the urine of patients with 
bacterial urinary tract infection [21], primary proximal 
tubules, human bronchial epithelial cells 16HBE1- 
4o- [13] and activated rodent macrophages [9-11,22], 
Previous studies have shown that iNOS interacts with 
cytoskeleton via components like a-actinin 4 [22] and 
other proteins harboring a spectrin-like motif [23]. We 
found that epithelial iNOS also colocalized with actin 
cytoskeleton proteins on the apical side of polarized 
intestinal cells. A recent study shows that the C-termi- 
nus of iNOS promotes in vitro interactions with the 
PDZ protein EBP50 [13]. Interestingly, EBP50 has dif­
ferent binding partners including ezrin that can be 
anchored to the actin cytoskeleton [24], The potential 
contribution of ezrin in apical distribution of iNOS is 
inferred from the observation that ezrin is concentra­
ted beneath the plasma membrane in apical microvilli 
in the epithelium of the small intestine [25].
Our solubilization protocol allows efficient recovery 
of iNOS activity and analysis of the monomer/dimer 
ratio in particulate fractions [14-16,26]. Previous inves­
tigations focused on cytosolic fractions or fractions 
soluble in 0.1% (v/v) TX-100 [22], which do not repre­
sent total iNOS [10]. Our data show that iNOS activity 
in epithelial cells is not only controlled by the number 
of iNOS molecules but also by the oligomerization fea­
ture in subcellular fractions. Previous studies have 
shown variation in iNOS specific activity in correlation 
to subcellular localization. Indeed, in murine macro­
phages stimulated by lipopolysaccharide, iNOS binds 
Rac2, a member of the Rho GTPase family, and over­
expression of Rac2 leads to a specific distribution of 
iNOS to the insoluble fraction. This effect is accom­
panied by increased iNOS activity without any change 
in iNOS protein levels [27]. Although the molecular 
mechanisms of Rac2-dependent regulation of iNOS 
activity are not elucidated yet, these data indicate 
compartmentalization-mediated regulation. In another 
study [22], disruption of iNOS interaction with cyto- 
skeletal protein a-actinin 4 resulted in iNOS redistribu­
tion and loss of activity.
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Targeting iNOS activity to specific cellular domains 
is independent of stimulation as a similar distribution 
is observed in transfected cells. Taken together these 
observations indicate that cells set up efficient strat­
egies to bring iNOS to where NO production is 
required. This may be necessary, as proposed by others 
[28], to direct NO toward extracellular pathogens, 
which, in intestinal cells, could be bacteria present in 
the intestinal lumen. This hypothesis is supported by 
positioning of iNOS on the apical side of intestinal 
crypts. Recently PDZ-binding a2/Pi-NO-sensitive 
guanylate cyclase [29] was also found expressed in 
intestinal tissue [30]. Active iNOS might be targeted to 
this NO-sensitive form of guanylate cyclase via associ­
ation with a PDZ protein anchoring both NO-sensitive 
guanylate cyclase and iNOS. NO can also interact with 
superoxide to form the strong oxidant peroxynitrite 
[31,32]. Superoxide is produced in vivo by membrane- 
associated NADPH oxidase complex, which is present 
in intestinal epithelial cells [33-35]. Exposure of 
NADPH oxidase expressing-human intestinal cells to 
flagellin can increase superoxide production [35]. Com­
bined with our observation that flagellin increases 
expression of a particulate fraction-associated iNOS, 
this suggests a colocalization and a functional inter­
action between these enzymes.
Different scenarios can be considered according to 
the iNOS dimer enrichment in the particulate fraction. 
One possibility is that the scaffolding protein anchor­
ing iNOS to the particulate fraction recognizes mainly 
the active dimer. This might explain why under dena­
turing conditions iNOS did not immunoprecipitate 
with PDZ protein EBP50 [13]. Alternatively, mono­
mers might have distinct turnover rates depending on 
their subcellular localization. The fact that the antifun­
gal molecule clotrimazole is able to change the ratio of 
dimeric to monomeric iNOS in the cytosol without 
affecting total protein amount [26,36] favors the hypo­
thesis that iNOS monomers are stable in the cytosol. 
On the other hand we have shown that proteasomal 
iNOS degradation seems to occur in detergent insol­
uble domains [17].
In conclusion, this study in cytokine- or flagellin-sti- 
mulated intestinal epithelial cells corroborated previous 
observations of iNOS accumulation in the particulate 
cellular fraction and showed for the first time that the 
monomeric to dimeric iNOS ratio is different in partic­
ulate vs. cytosolic fractions. These results indicate a 
new regulation of iNOS activity relying on localiza­
tion-dependent molecular conformation and provide 
tools for further investigation of the mechanisms 
involved in this differential iNOS distribution.
Experimental procedures
Cell culture
Human intestinal epithelial DLD-1 cells (ATCC CCL-221) 
were cultured and stimulated with 100 l/tr.L interferon-y, 
200 l/tr.L interleukin-6 (Roche Molecular Biochemicals, 
Rotkreuz, Switzerland), and 0.5 nginL interleukin-1|3 
(Calbiochem, La Jolla, CA, USA) to induce iNOS as des­
cribed previously [17], A stimulation period of 14 h was 
selected from a time course study establishing that iNOS 
production and activity, which were undetected in control 
cells, reached maximal levels within 10 h of cytokine expo­
sure and then remained stable during the following 6 h [37],
To investigate iNOS induction in polarized epithelial 
cells, human intestinal epithelial Caco-2 clone 1 cells, stimu­
lated with cytokines as above were used. Caco-2 cells were 
grown either on plastic dishes as described previously [20], 
or on Transwell (6 mm in diameter, 3 gm pore; Corning 
Costar, Cambridge, MA, USA) where integrity of the epi­
thelial layer was verified by measurement of transepithelial 
resistance [38],
In some experiments DLD-1 or Caco-2 cells transfected 
with human iNOS coding cDNA [39] subcloned into the 
Notl site of the pCIpuro vector, which contains a puro- 
mycin resistance gene (kindly provided by J Mirkovitch, 
Swiss Institute for Experimental Cancer Research, Epalin- 
ges, Switzerland) were used.
Mice exposure to flagellin
Protocols involving animals were reviewed and approved by 
the State Authority (Commission du Service Veterinaire Can­
tonal, Lausanne, Switzerland). C57BL/6 mice (8-10 weeks 
old) were challenged (intravenously) with 1 gg of flagellin 
purified as described previously [38], Mice were killed after 
2 h by cervical dislocation and duodenal tissue was processed 
for RNA and protein analysis as described below.
Cell or tissue lysate preparation and subcellular 
fractionation
Cell monolayers or 1 cm duodenum tissue were suspended in 
lysis buffer (50 mM Hepes pH 7.4, 1 mM EGTA, 10% gly­
cerol, 2 gM tetrahydrobiopterin, 2 gM FAD, 5 gginL pep- 
statin, 3 gg inL aprotinin, 10 gg inL leupeptin, 0.1 mM 
4-(2-aminoethyl)-benzenesulfonyl fluoride, 1 mM sodium 
vanadate and 50 mM sodium fluoride). Cell samples were 
then homogenized by three freeze/thaw cycles. Tissues were 
homogenized using Polytron (Kinematica AG, Littau, Swit­
zerland). Aliquots of homogenate were centrifuged at 
100 000 g for 15 min at 4 °C (Beckman Optima TLX Ultra­
centrifuge, Nyon, Switzerland). The pellet corresponding to 
the particulate fraction (48.4 ± 2.7% and 53.8 ± 4.7% of 
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the protein in cultured cells and tissue, respectively) was re­
suspended by two freeze/thaw cycles in a final volume of lysis 
buffer equal to the cytosolic volume. To check cell fraction­
ation, activity of the cytosolic marker lactate dehydrogenase 
was measured [40] and Western blot analysis of Na+/K + - 
ATPase, a membrane marker, was performed using an anti­
body raised against rabbit oi-subunit (1 : 20 000) [41],
To further characterize epithelial iNOS, the particulate 
fraction, was exposed to one of the following treatments: (a) 
extraction with 1 M KC1; (b) incubation for 1 h at 4 °C with 
one of the following components prepared in lysis buffer: 
0.1 M Na2CO3 pH 11; 125 mM NaCl; 1% (v/v) TX-100; 1% 
(v/v) TX-100 in the presence of 125 mM NaCl; (c) resuspen­
sion in 0.17 M sucrose, 30% (v/v) glycerol, 10 mM glycine 
buffer, pH 8.0, containing 0.25% (v/v) each of DOC and 
Lubrol PX and 1.6 pM CaCl2 and immediate sonication at 
full power for 10 s at 4 °C [42], All extracts were separated 
by centrifugation at 100 000 g. The supernatant, correspond­
ing to the soluble fraction, was retained and the resulting 
pellet, corresponding to insoluble material, was resuspended 
by sonication in the same volume as supernatant.
iNOS activity
Calcium-independent NOS activity was assessed by measur­
ing the conversion of L-[H3]arginine to L-[H3]citrulline, as 
described previously [43], iNOS specific activity was calcula­
ted from the ratio of citrulline production to iNOS protein 
levels.
Western blot analysis
Proteins determination and Western blot analysis were per­
formed as described previously [17,20], Denatured proteins 
were separated on 7.5% SDS/polyacrylamide gel. Antibody 
raised against human iNOS (kind gift of RA Mumford, 
Merck Research Laboratories, Rahway, NJ, USA), or 
murine iNOS (Transduction Laboratories, Lexington, KY, 
USA) were diluted at 1 : 40 000 or 1: 2 000, respectively. 
Detection was achieved by enhanced chemiluminescence 
(Amersham Pharmacia, Dübendorf, Switzerland) and den­
sitometry (Imagequant, Amersham Bioscience, Uppsala, 
Sweden) was performed on nonsaturated films. An internal 
calibration curve, obtained with increasing amounts of 
homogenate, allowed the determination of the linearity con­
ditions of the luminescence reaction.
Laser dissection microscopy, RNA isolation and 
real-time PCR
The gut was rinsed with ice-chilled NaCl/P, to remove the 
intestinal content. One centimeter long duodenum segments 
were cut and villi epithelium was microdissected to extract 
RNA and prepare cDNA as described previously [44], The 
latter was amplified by the SYBR-Green real-time PCR 
assay, and products were detected on a Prism 5700 detec­
tion system (ABI/PerkinElmer, Foster City, CA, USA). 
Beta actin RNA was used to standardize the total amount 
of cDNA. Primers for iNOS (GCTGCCAGGGTCACAAC 
TTT and ACCAGTGACACTGTGTCCCGT) and for beta 
actin (GCTTCTTTGCAGCTCCTTCGT and CGTCATCC 
ATGGCGAACTG) yielded PCR products of 71 and 
59 bp, respectively. Specificity of PCR was checked by ana­
lyzing the melting curve. Relative mRNA levels were deter­
mined by comparing (a) the PCR cycle threshold between 
cDNA of iNOS and beta actin (AC), and (b) AC values 
between treated and untreated conditions (AAC) as des­
cribed previously [7,44],
Immunostaining and confocal microscopy
Caco-2 cells grown on Transwell filters were fixed with 
NaCl/P, 4% (v/v) paraformaldehyde then permeabilized for 
5 min with NaCl/P, 1% (v/v) TX-100. Immunostaining was 
carried out by incubation with NO53 anti-iNOS IgG 
1 : 10 000 followed by detection using Cy3-conjugated anti­
rabbit IgG (Jackson Immunoresearch Laboratories, West 
Grove, PA, USA) at a dilution of 1 : 200 for 45 min. Fila­
mentous actin expression was detected with Alexa Fluor 488 
phalloidin (Molecular Probes, Inc., Eugene, OR, USA). 
Caco-2 monolayers were analyzed by an LSM-410 Zeiss con­
focal microscope (Feldbach, Switzerland). XZ sections of 
monolayers were performed to determine iNOS localization.
Tissue specimens were frozen in OCT embedding com­
pound (Sakura Finetek Europe, Zoeterwoude, the Nether­
lands) and stored at -80 °C. Sections (5 pm thick) were fixed 
with NaCl/P, 4% (v/v) paraformaldehyde then immersed in 
0.01 M sodium citrate buffer (pH 6.0) and placed into a 
microwave oven for 10 min before incubation with the pri­
mary antiserum. Antigen retrieval treatment significantly 
reduced the strong background obtained in tissue using anti­
murine iNOS IgG. Sections were permeabilized for 5 min 
with NaCl/P, 0.2% (v/v) TX-100, then sequentially incuba­
ted with NaCl/P, containing 2% (w/v) BSA, anti-murine 
iNOS (overnight at 4 °C), followed by detection using Cy3- 
conjugated anti-rabbit IgG. Because microwave treatment 
abolishes phalloidin immunoreactivity, phalloidin staining 
was not performed on tissue sections. For control of unspe­
cific binding of the antibodies, we performed control incuba­
tions by applications of isotype matched antibodies directed 
against different defined antigens. All control experiments 
were negative. Immunofluorescence was observed with a 
Zeiss Axiophot immunofluorescence microscope.
Gel filtration chromatography
To determine the relative amounts of iNOS dimers and 
monomers present in cytosolic and solubilized particulate 
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fractions, size exclusion chromatography was carried out at 
4 °C using a Sephadex G200 gel filtration column as already 
described for cytosolic fractions [15,16] or fractions soluble 
in TX-100 [22], The column was equilibrated with 40 mM 
Bistris buffer pH 7.4, containing 2 mM dithiothreitol, 10% 
(v/v) glycerol and 100 mM NaCl for human iNOS or 
200 mM NaCl for murine iNOS [15,16], Fractions were ana­
lyzed for iNOS protein by Western blot. The molecular 
masses of the protein fractions were estimated relative to gel 
filtration molecular mass standards. Gel filtration fractions 
that fell within a molecular mass range of 600-50 kDa (14 
fractions) were analyzed by Western blot as described 
above. The intensity of the iNOS bands was quantitated by 
densitometry, integrated, and the ratio between monomers 
and dimers was calculated from these values.
Data analysis
Values are means ± SEM of n independent experiments 
and statistical analysis was performed using Student’s t-test.
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